Functionalized Nanoparticles for Isothermal Protein Precipitation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current affinity precipitation technologies for protein purification, such as those using elastin-like polypeptides (ELPs), require high temperatures and salt concentrations, which can lead to antibody aggregation, denaturation, and operational inefficiencies, and lack selectivity.

Innovation Solution

The development of nanoparticles with a scaffolding domain, such as the E2 core of the pyruvate dehydrogenase enzyme complex, fused with an affinity domain like the Z-domain and a stimuli-responsive precipitation domain, allowing for isothermal phase transition at low salt concentrations, enabling efficient and selective protein purification.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If conventional affinity precipitation uses high salt concentrations (exceeding 1 M) and high temperatures (37°C) to precipitate proteins, then precipitation efficiency is improved, but protein aggregation, denaturation, and loss of activity occur

Engineering Contradiction:
Improveprecipitation efficiencyVSAvoidprotein aggregation and denaturation
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

The patent modifies the precipitation conditions by changing the physical-chemical parameters of the system. The functionalized nanoparticles enable precipitation at lower salt concentrations (below 1 M) and lower temperatures (below 37°C) while maintaining high efficiency. This is achieved by incorporating specific ligands (Protein A, Protein G, or Protein L) on the nanoparticle surface that have high affinity for the Fc region of antibodies, allowing selective binding and precipitation under milder conditions that prevent protein denaturation.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent employs composite nanoparticle structures combining inorganic cores (such as silica or metal nanoparticles) with organic functional layers. These functionalized nanoparticles integrate multiple properties: the core provides structural stability and surface area, while the surface-bound affinity ligands provide selective binding. This composite structure enables efficient precipitation under mild conditions, resolving the contradiction between precipitation efficiency and protein stability.

Inventive Principle:
Principle #40Composite materials

2Reliability

If Protein A chromatography is used for antibody purification, then selectivity and yield are improved, but throughput, scale-up capability, and cost are limited

Engineering Contradiction:
Improvepurification selectivity and yieldVSAvoidthroughput and scale-up capability
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The patent replaces the chromatography mechanical system (column-based flow through resin beads) with a nanoparticle-based precipitation system. Instead of passing solution through a chromatography column, the functionalized nanoparticles are mixed with the antibody solution, allowing binding and precipitation to occur in a well or reactor. This substitution maintains the high selectivity of affinity binding while enabling easier scale-up by simply increasing the nanoparticle dosage without requiring larger columns or higher flow rates.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The functionalized nanoparticles serve multiple functions: they provide affinity binding for selective capture, form visible precipitates for easy separation, and can be reused after regeneration. The same nanoparticle formulation can be applied to different antibody types by adjusting the specific ligand used (Protein A, G, or L), making the platform universally applicable while maintaining high throughput and scale-up capability.

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Ease of manufacture

If ELP-based affinity precipitation is used to avoid high costs, then cost efficiency is improved, but selectivity is reduced

Engineering Contradiction:
Improvecost efficiencyVSAvoidpurification selectivity
Core Design Contradiction:
Ease of manufactureVSReliability

Solution Approach 1:

The patent merges the cost advantages of precipitation methods with the selectivity of affinity chromatography by functionalizing inexpensive nanoparticle cores with affinity ligands. The inorganic nanoparticle core (silica, metal oxide, or metal) provides a cheap, scalable platform, while the surface-bound Protein A, G, or L ligands provide high selectivity for antibody Fc regions. This combination achieves both cost efficiency and high purification selectivity, overcoming the limitation of conventional ELP precipitation.

Inventive Principle:
Principle #5Merging (Combining)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach significantly reduces the required salt and temperature for protein precipitation, minimizing product degradation and operational burdens, while achieving high purification yields and selectivity, with the nanoparticles capable of forming large aggregates for efficient separation and being recyclable.

Implementation Method 1

The nanoparticle is capable of binding specifically to the target protein in the first solution

Methodology Applied
Scientific EffectAffinity binding: Adsorption

Implementation Method 2

The nanoparticle is capable of binding specifically to the target protein in the first solution and precipitating with the target protein out of the first solution in response to a first stimulus

Methodology Applied
Scientific EffectPhase transition: Phase Change

Data Source

PatentUS11149060B2Functionalized nanoparticles for enhanced affinity precipitation of proteins
Publication Date: 2021.10.19 UNIVERSITY OF DELAWARE
  • US11149060B2 patent drawing
  • US11149060B2 patent drawing
  • US11149060B2 patent drawing

AI summary

The present invention provides a nanoparticle capable of binding specifically to a target protein in a solution and precipitating with the target protein out of the solution upon addition of the target protein to the solution. The precipitation may be reversed release the target protein from the nanoparticle, which may be reused for precipitating the target protein. Also provided are a method for purifying a target protein by affinity precipitation using the nanoparticle without chromatography and a method for preparing the nanoparticle.